Furthermore, the samples with higher METTL14 expression displayed strong staining for miR‐6769b‐3p and miR‐499a‐3p and weak staining for SLC2A3 and PGAM1, while samples with low expression of METTL14 were with low levels of miR‐6769b‐3p and miR‐499a‐3p, and high levels of SLC2A3 and PGAM1 in p53‐WT CRC samples (Fig 6B and C). The gene discussed is METTL14; the disease is colorectal carcinoma.